Areas eligible for SMC and areas where SMC is implemented in 2020
Togo 2021 SMC season |
# of children targeted |
# of children reached |
Coverage |
Cycle 1 |
453,716 |
448,401 |
99% |
Cycle 2 |
470,616 |
464,781 |
99% |
Cycle 3 |
500,074 |
491,628 |
98% |
Cycle 4 |
507896 |
499176 |
98% |
Monitoring for coverage and compliance in the 2021 SMC season
Monitoring of coverage
- Door-to-door strategy with systematic registration of target children followed by treatment of eligible children
- Daily reporting by distributor agents and transmission to higher levels
- Daily monitoring at each level to assess completeness and coverage
- Summary of activities at district and regional level
Monitoring compliance
- Supervision of actors with convenience surveys in households
- Rapid evaluation with the cluster method at the end of each cycle
- Coverage survey
Monitoring efficacy
- Monthly monitoring of the evolution of malaria cases and related deaths through the national health information system
Successes, opportunities, challenges and solutions in the 2021 SMC season
Successes
- Revision of tools, taking into account the covid-19 aspect
- Sufficient mobilization of personal protective equipment against covid-19
- Training of actors
- Video support
- Starting SMC on time (June)
- Observance of 28-day intervals between cycles
- Administering 4 cycles
Follow up actions
- Complete planning/micro-planning by the end of March
- Digitization of the SMC linked to DHIS2
- Timely acquisition of inputs and implementation tools
- Impact study (pre and post treatment)
- Study for the geographical extension of SMC
- Carrying out studies as part of the OPT-SMC project
Challenges
- Calendar conflicts
- Acquisition of inputs on time (UNICEF)
Follow-up actions
- Fixing of completion dates from microplanning with operational actors
- Advocacy with UNICEF to involve the NMCP in the ordering process as well as in delivery and monitoring.
- Currently, inputs from the Global Fund are used in all areas prior to reimbursement by UNICEF
Research priorities for 2021 and beyond
- There were no research priorities for 2021. However, for 2022 and beyond, these priorities were planned:
- Directly observed treatment (2022)
- Impact of SMC on malaria morbidity and mortality in target regions (2023)
Financing
- Malaria Consortium
- OPT-SMC